Literature DB >> 2909684

Lack of histopathological correlation of malignant ependymomas with postoperative survival.

G W Ross1, L J Rubinstein.   

Abstract

It is widely believed that an important determinant of clinical behavior and prognosis in patients harboring an ependymoma is the histological grade of malignancy of the tumor. Excluding from the present analysis examples of ependymoblastoma (a highly cellular, embryonal tumor occurring in children, with a notably poor prognosis and a tendency to subarachnoid spread), an attempt was made to correlate 15 cases of histologically malignant ependymoma with clinical recurrence and postoperative patient survival times. Ten patients (67%) were alive from 15 months to 14 years after surgery (median survival time 8.8 years); one patient had a histologically benign recurrence 11 years after surgical resection. Five patients (33%) died from a local recurrence of their tumor; their postoperative survival times ranged from 13 months to 6 years (median 2.5 years). The prognosis of malignant ependymomas is therefore highly variable. No correlation was possible between the tumor's histological features, site, or likelihood of recurrence. This lack of clinicohistopathological concordance contrasts with the known correlations that exist in astrocytomas.

Entities:  

Mesh:

Year:  1989        PMID: 2909684     DOI: 10.3171/jns.1989.70.1.0031

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  40 in total

Review 1.  Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis.

Authors:  Stacey L Berg; Marc C Chamberlain
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

2.  Infrequency of p53 gene mutations in ependymomas.

Authors:  K L Fink; E J Rushing; S C Schold; P D Nisen
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

Review 3.  Pediatric brain tumors: current treatment strategies and future therapeutic approaches.

Authors:  Sabine Mueller; Susan Chang
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

4.  A grading study of gliomas using computer aided malignancy classification and histologic morphometry.

Authors:  S Sharma; A K Karak; C Sarkar; G Gomathy; A K Banerji; H P Schmitt
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

5.  Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.

Authors:  Y Hirose; K Aldape; A Bollen; C D James; D Brat; K Lamborn; M Berger; B G Feuerstein
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

6.  Localization and significance of peanut agglutinin-binding sites on ependymoma cells.

Authors:  J Kuratsu; N Sueyoshi; Y Mihara; Y Ushio
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Histologic prognostic factors in ependymoma.

Authors:  D Schiffer; A Chiò; M T Giordana; A Migheli; L Palma; B Pollo; R Soffietti; A Tribolo
Journal:  Childs Nerv Syst       Date:  1991-08       Impact factor: 1.475

8.  Malignant hemispheric tumors in childhood.

Authors:  E Hoppe-Hirsch; J F Hirsch; A Lellouch-Tubiana; A Pierre-Kahn; C Sainte-Rose; D Renier
Journal:  Childs Nerv Syst       Date:  1993-06       Impact factor: 1.475

Review 9.  Survival following treatment for intracranial ependymoma: a review.

Authors:  G Tamburrini; M D'Ercole; B L Pettorini; M Caldarelli; L Massimi; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2009-04-22       Impact factor: 1.475

10.  Unique molecular characteristics of pediatric myxopapillary ependymoma.

Authors:  Valerie N Barton; Andrew M Donson; Bette K Kleinschmidt-DeMasters; Diane K Birks; Michael H Handler; Nicholas K Foreman
Journal:  Brain Pathol       Date:  2009-09-10       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.